Literature DB >> 23027187

A case of daptomycin-induced immune thrombocytopenia.

Charles Grégoire1, Caren Brumpt, Delphine Loirat, Nicolas Lau, Cedric Bruel, Francois Philippart, Carine Couzigou, Maité Garrouste-Orgeas, Benoit Misset.   

Abstract

We report a case of severe daptomycin-induced immune thrombocytopenia in a patient treated for methicillin-resistant Staphylococcus epidermidis and ampicillin-resistant Enterococcus faecalis bacteremia acquired in an intensive care unit. Serum antibodies bound to platelets in the presence of daptomycin on flow cytometry. There was no evidence of other causes of thrombocytopenia. The patient died of brain herniation complicating extensive cerebral hemorrhage. To our knowledge, this is the first described case of daptomycin-induced thrombocytopenia.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23027187      PMCID: PMC3497155          DOI: 10.1128/AAC.01787-12

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  5 in total

Review 1.  Drug-induced immune thrombocytopenia.

Authors:  Richard H Aster; Daniel W Bougie
Journal:  N Engl J Med       Date:  2007-08-09       Impact factor: 91.245

2.  Daptomycin versus vancomycin for bloodstream infections due to methicillin-resistant Staphylococcus aureus with a high vancomycin minimum inhibitory concentration: a case-control study.

Authors:  Carol L Moore; Paola Osaki-Kiyan; Nadia Z Haque; Mary Beth Perri; Susan Donabedian; Marcus J Zervos
Journal:  Clin Infect Dis       Date:  2011-11-21       Impact factor: 9.079

3.  Patients with quinine-induced immune thrombocytopenia have both "drug-dependent" and "drug-specific" antibodies.

Authors:  Daniel W Bougie; Peter R Wilker; Richard H Aster
Journal:  Blood       Date:  2006-08-01       Impact factor: 22.113

4.  Recurrent acute thrombocytopenia in the hospitalized patient: sepsis, DIC, HIT, or antibiotic-induced thrombocytopenia.

Authors:  Talla A Rousan; Ibrahim T Aldoss; Benjamin D Cowley; Brian R Curtis; Daniel W Bougie; Richard H Aster; James N George
Journal:  Am J Hematol       Date:  2010-01       Impact factor: 10.047

Review 5.  Daptomycin: another novel agent for treating infections due to drug-resistant gram-positive pathogens.

Authors:  Christopher F Carpenter; Henry F Chambers
Journal:  Clin Infect Dis       Date:  2004-03-11       Impact factor: 9.079

  5 in total
  1 in total

1.  Tazobactam and piperacillin-induced thrombocytopenia: A case report.

Authors:  Hong Chen; Zhen Fan; Fei Guo; Yumin Yang; Jie Li; Jie Zhang; Yudan Wang; Jianwei LE; Zhiyu Wang; Jianhua Zhu
Journal:  Exp Ther Med       Date:  2016-02-09       Impact factor: 2.447

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.